| 000 | 01784 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514212208.0 | ||
| 264 | 0 | _c20050502 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1019-6439 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVigneswaran, Nadarajah | |
| 245 | 0 | 0 |
_aDifferential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cJan 2005 |
||
| 300 |
_a103-12 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aApoptosis Regulatory Proteins |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 | _aCaspase 8 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCystatins _xgenetics |
| 650 | 0 | 4 |
_aDipeptides _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratins _xanalysis |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xtoxicity |
| 650 | 0 | 4 |
_aMouth Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xanalysis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 | _aTNF-Related Apoptosis-Inducing Ligand |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xtoxicity |
| 700 | 1 | _aWu, Jean | |
| 700 | 1 | _aNagaraj, Nagathihalli | |
| 700 | 1 | _aAdler-Storthz, Karen | |
| 700 | 1 | _aZacharias, Wolfgang | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 26 _gno. 1 _gp. 103-12 |
|
| 999 |
_c15270795 _d15270795 |
||